Predictive Value of Cognitive Tests Performed for the Diagnosis of Alzheimer's Disease and Related Disorders

Alzheimer's Disease Clinical Trial

— EVATEM  

Official title:

Valeur prédictive d'Une évaluation Cognitive standardisée en Centre d'Examens de Santé Pour le Diagnostic de la Maladie d'Alzheimer ou Des Maladies apparentées en Population générale Chez Les Plus de 65 Ans Avec Plainte mnésique

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01316562
• Other study ID #: 2009-025B
• Status: Recruiting
• Phase: N/A
• First received: March 11, 2011
• Last updated: March 8, 2012
• Start date: July 2009
• Est. completion date: July 2012

Study information

• Verified date: March 2011
• Source: University Hospital, Angers
• Contact: Bruno Fantino, Professor
• Phone: (+33)472513647
• Email: bruno.fantino[@]ces.cnamts.fr
• Is FDA regulated: No
• Health authority: France: Ministry of Health
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to determine the predictive value of standardized cognitive tests performed in health examination centres for the diagnosis of Alzheimer's disease and related disorders among adults aged 65 years and older with a subjective memory complaint.

Description:

The main objective of this study is to determine the predictive value of standardized cognitive tests performed in health examination centres for the diagnosis of Alzheimer's disease and related disorders among adults aged 65 years and older with a subjective memory complaint.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 500
• Est. completion date: July 2012
• Est. primary completion date: July 2011
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• Age = 65 years

• Community-dwellers

• Volunteers receiving a free medical examination in Health examination centre

• Subjective memory complaint

Exclusion Criteria:

• Known dementia

• Sensory deficit compromising the cognitive evaluation

• Poor workmanship of the written or oral French language

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Alzheimer Disease
• Alzheimer's Disease
• Impaired Cognition
• Memory Disorders

Locations

Country	Name	City	State
France	CES Baraban	Lyon

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Angers

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Score of episodic memory and executive psychometric tests		Baseline	No